Bal Pharma Ltd share price logo

Bal Pharma Ltd Share Price(BALPHARMA)

Check the latest share price of Bal Pharma Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹97.520.8%

as on 04:01PM, 16 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Bal Pharma Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹95.91
    Day's Price Range
    ₹98.74
  • 52 Week's Low

    52 Week's High

    ₹78.06
    52-Week Price Range
    ₹157.98
1 Month Return-9.08 %
3 Month Return+ 3.92 %
1 Year Return-3.78 %
3 Year Return-4.59 %
5 Year Return+ 175.64 %
Previous Close₹96.75
Open₹98.00
Volume47.62K
Upper Circuit₹106.42
Lower Circuit₹87.07

Bal Pharma Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹154.03 Cr

Return on Equity (ROE)

10.19

PE Ratio (TTM)

19.87

Return on capital employed (ROCE)

11.63

Industry PE ratio

54.98

Beta (LTM)

0.7

P/B Ratio

1.37

Dividend Yield

1.31

PEG Ratio

7.58

Quarterly Earnings Growth YOY

-38.82

EPS (TTM)

4.71

Sector

Pharmaceuticals

Book Value

43.42

Technical Analysis

How to invest in Bal Pharma Ltd?

Investing in Bal Pharma Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Bal Pharma Ltd or BALPHARMA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Bal Pharma Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Bal Pharma Ltd with just a few clicks!

Bal Pharma Ltd Stock's Interest Amongst Investors

-72%

Period May 17, 2025 to Apr 17, 2025. Change in 30 Days vs previous period

Search interest for Bal Pharma Ltd Stock has decreased by -72% in the last 30 days, reflecting a downward trend in search activity.

Bal Pharma Ltd Valuation

Track how the P/E of Bal Pharma Ltd has moved over time to understand valuation trends.

Bal Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-535.88x)

June 15, 2018

Today (19.87x)

May 15, 2025

Industry (54.98x)

May 15, 2025

Highest (203.65x)

September 12, 2018

LowHigh

Today’s Price to Earnings Ratio: 19.87x

Bal Pharma Ltd Financials

Get the annual and quarterly financial summary of Bal Pharma Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue

(in ₹ Cr)

82 (0%)95 (16%)74 (21%)74 (1%)73 (1%)
Net Income

(in ₹ Cr)

1 (0%)6 (551%)0 (95%)1 (300%)1 (50%)
Net Profit Margin1.04% (0%)5.84% (462%)0.35% (94%)1.41% (303%)0.71% (50%)
Value in ₹ crore
Details2021202220232024
Total Assets

(in ₹ Cr)

262 (0%)292 (12%)350 (20%)362 (3%)
Total Liabilities

(in ₹ Cr)

182 (0%)205 (13%)254 (24%)257 (1%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow

(in ₹ Cr)

22 (0%)10 (53%)31 (199%)5 (82%)29 (438%)

Bal Pharma Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Bal Pharma Ltd.

  • Bal Pharma Ltd Earnings Results

    Bal Pharma Ltd’s net profit fell -46.07% since last year same period to ₹0.48Cr in the Q3 2024-2025. On a quarterly growth basis, Bal Pharma Ltd has generated -53.85% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Bal Pharma Ltd Dividends May,2024

    In the quarter ending March 2024, Bal Pharma Ltd has declared dividend of ₹1.20 - translating a dividend yield of 2.26%.

    Read More about Dividends

Bal Pharma Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Bal Pharma Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
50.86%
0.00
Foreign Institutions
0.14%
0.00
Mutual Funds
0%
0.00
Retail Investors
49%
0.00
Others
0%
0.00

Bal Pharma Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Bal Pharma Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA154.0335.13%0.797339
NA28.58-6.58%0.781150
NA3,546.96172.56%0.5187582
NA750.93-7%0.5641338
BUY6,991.0720.87%0.53311,151

Insights on Bal Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 73.49 Cr → 73.66 Cr (in ₹), with an average increase of 0.2% per quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 49.00% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 153.0% return, outperforming this stock by 157.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.86% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.14% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 58.1% return, outperforming this stock by 61.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.04 Cr → 0.48 Cr (in ₹), with an average decrease of 53.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, BALPHARMA stock has moved down by -9.1%

About Bal Pharma Ltd

BPL, a member of Macrolabs group, was incorporated in May 1987 and took over a pharmaceutical product manufacturing unit in Bangalore worth Rs 25.18 lac. The company manufactures and markets, pharmaceutical formulations such as paracetamol, aluminium hydroxide and povidone iodine. It came out with a public issue in Feb 1995 for the manufacturing of bulk drugs and expansion of pharmaceutical formulations. Additions to product range include AZIWIN CAFIMOL, CORTIDERM, Zanovid, Aziwin Dry Syrup, Meloxi Ocium, M Progit, MPS and Cardiac Specialities, AmilorideBenzydamine and Ebastine were added in 2002. BPL promotes its products through the sales force of the Macrolabs group and plans to launch its own soon. The unit has become a division of Bal Pharma Limited, thus marking an expansion in the drug production.

Revenue: ₹73.15Cr as on December 2024 (Q4 24)
Net Profit: ₹0.52Cr as on December 2024 (Q4 24)
Listing date: 08 May, 2006
OrganisationBal Pharma Ltd
HeadquartersBangalore
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Bal Pharma Ltd price today?

Bal Pharma Ltd share price today stands at ₹97.52, Open: ₹98, Previous Close: ₹96.75, High: ₹98.74, Low: ₹95.91, 52 Week High: ₹157.98, 52 Week Low: ₹78.06.

How to Buy Bal Pharma Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Bal Pharma Ltd shares

What are today's traded volumes of Bal Pharma Ltd?

Today's traded volume of Bal Pharma Ltd(BALPHARMA) is 47.62K.

What is today's market capitalisation of Bal Pharma Ltd?

Today's market capitalisation of Bal Pharma Ltd(BALPHARMA) is ₹154.03 Cr.

What is the 52 Week High and Low Range of Bal Pharma Ltd?

Bal Pharma Ltd (BALPHARMA)
Price
52 Week High
₹157.98
52 Week Low
₹78.06

How much percentage Bal Pharma Ltd is down from its 52 Week High?

Bal Pharma Ltd (BALPHARMA) share price is ₹97.52. It is down -38.27% from its 52 Week High price of ₹157.98

How much percentage Bal Pharma Ltd is up from its 52 Week low?

Bal Pharma Ltd (BALPHARMA) share price is ₹97.52. It is up 24.93% from its 52 Week Low price of ₹78.06